Enoxaparin sodium (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Enoxaparin sodium drug offered from Fresenius Kabi USA, LLC. This Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | enoxaparin sodium |
SUBSTANCE NAME: | ENOXAPARIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-02-20 |
END MARKETING DATE: | 0000-00-00 |
Enoxaparin sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Enoxaparin sodium from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/3mL) |
START MARKETING DATE: | 2015-02-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-565_18f764b1-dca2-4d03-9b54-c7a24fb22891 |
PRODUCT NDC: | 63323-565 |
APPLICATION NUMBER: | NDA020164 |
Other ENOXAPARIN SODIUM Pharmaceutical Manufacturers / Labelers: